Newsroom

Sorted by: Latest

-

Massachusetts Financial Services Company UK Regulatory Announcement: Form 8.3

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Massachusetts Financial Services Company (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...
-

Massachusetts Financial Services Company UK Regulatory Announcement: Form 8.3

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Massachusetts Financial Services Company (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...
-

The Arch's Anvil Expands Leadership Team and Platform as Advisory Firms Face Increasing Organizational Complexity

SEATTLE--(BUSINESS WIRE)--The Arch's Anvil, an operational consulting firm for independent registered investment advisors (RIAs), today announced the addition of Tamara Stelting as Executive Consultant and an expansion of its consulting platform. The firm will detail both during a live webinar, "Growing Your Firm Beyond You," on Thursday, August 6.The expansion follows a recent organizational diagnostic conducted by The Arch's Anvil, which found a consistent pattern among participating firms: le...
-

T3 Technology Conference Opens Registration for 2027 Event Focused on the AI-Augmented Advisor

LAS VEGAS--(BUSINESS WIRE)--Registration is now open for the 2027 T3 Technology Conference, the wealth management industry’s longest-running technology conference for financial advisors and enterprise technology decision-makers, produced by T3 Technology Tools for Today. Scheduled for March 22-25, 2027, at The Cosmopolitan of Las Vegas, the T3 conference will once again bring together financial advisors, wealth management executives, fintech innovators, and industry leaders to explore how artif...
-

Aeonsemi Unveils LumaReach™

SANTA CLARA, Calif.--(BUSINESS WIRE)--Aeonsemi (www.aeonsemi.com), a leader in mixed-signal and DSP connectivity ICs, today announced LumaReach™, the industry’s first commercially available 10 Gbps Ethernet-over-coax network controller IC. Developed as a new fiber-extension technology, LumaReach™ delivers fiber-class latency and bandwidth over existing RG6 and RG59 coaxial cabling already installed in approximately 150 million homes across North America and Europe, enabling service providers to...
-

Marsh Reports Second Quarter 2026 Results

NEW YORK--(BUSINESS WIRE)--Marsh (NYSE: MRSH), a global leader in risk, reinsurance and capital, people and investments, and management consulting, today reported financial results for the second quarter ended June 30, 2026. John Doyle, President and CEO, said: "I am pleased with our solid results in the quarter and our execution in a dynamic environment. Our performance in the first half underscores strong demand for Marsh's expertise and capabilities across risk, people, strategy, and investm...
-

Ashlins Pharmaceuticals and Lee's Pharm Announce Exclusive License and Supply Agreement Valued at Up to $31 Million

NEW YORK--(BUSINESS WIRE)--Ashlins Pharmaceuticals today announced that its wholly owned subsidiary, Ashlins Ocular Pharmaceuticals, Inc., has entered into an exclusive license and supply agreement with Lee’s Pharmaceutical Holdings Limited (HKEX: 0950), a publicly listed biopharmaceutical company with more than 30 years of industry experience. Under the agreement, Ashlins has obtained exclusive rights to develop and commercialize certain drug products incorporating Lee’s Pharm’s interferon alp...
-

Native Acquires Frontline Research Group to Build the Agentic AI Data Layer for Africa’s $1.7 Trillion Traditional Trade Market

NEW YORK--(BUSINESS WIRE)--Native, the agentic intelligence company building the operating system for offline trade, today announced it has acquired Frontline Research Group, a leading market intelligence business serving consumer goods companies across more than 14 African markets. Native is acquiring Frontline to add independent market share data that tells brands whether their commercial actions are translating into real gains. Together, the two companies give consumer goods companies a comp...
-

Redwire Opens State-of-the-Art Facility in Indiana to Accelerate Space-Enabled R&D and Manufacturing with a Focus on Next-Gen Drug Development and Human Health Breakthroughs

JACKSONVILLE, Fla.--(BUSINESS WIRE)--Redwire Corporation (NYSE: RDW), a global leader in space and defense technology solutions, has opened its new 30,000 square foot state-of-the-art, vertically-integrated research and microgravity payload development facility in Georgetown, Indiana. The facility will serve as a global hub supporting accelerated demand as the company continues to expand its leadership in space-enabled research, development, and manufacturing with a focus on pharmaceutical/biot...
-

VENU Secures Bridge Loan Financing Facility with Ryan, LLC to Advance National Expansion

COLORADO SPRINGS, Colo.--(BUSINESS WIRE)--Venu Holding Corporation ("VENU" or the “Company”) (NYSE AMERICAN: VENU), an owner, operator, and developer of premium live entertainment destinations, today announced it has secured a bridge loan financing facility with Ryan, LLC ("Ryan"). The facility is intended to fund ongoing construction costs for the Company's premium 20,000-seat entertainment destination, Sunset Amphitheater in McKinney, Texas, targeted to open in the first quarter of 2027.The $2...